The prevalence of congenital heart defects is approximately 1% of all live births. Identifying the genes responsible for cardiac malformation is the first step to understand pathogenesis. Heterozygous mutations in the CSX/NKX2-5 (NKX2E) gene have been identified to cause atrial septal defect (ASD) and/or atrioventricular (AV) conduction disturbance in some families. However, there is great variability in expressivity of the phenotype between the patients with a CSX/NKX2-5 mutation. We screened four sporadic patients and three index cases of families with ASD and/or conduction defects. In one of them, a CSX/NKX2-5 mutation was identified. This novel mutation (p.Tyr256X) was inherited in a three-generation family causing five individuals to have cardiac anomalies ranging from ASD to arrhythmias. Interestingly, all the observed AV conduction disturbances were at the nodal level, manifesting first as an AV block of the first degree and evolving toward a second-degree block. Atrial fibrillation, previously reported in three individuals with CSX/NKX2-5 mutations, was observed in three patients.
Introduction
The most frequent phenotype of patients carrying a CSX/ NKX2-5 mutation is atrioventricular (AV) conduction defect (AV block) and secundum atrial septal defect (ASD) (MIM# 108900). Ventricular septal defect, tetralogy of Fallot, subvalvular aortic stenosis, ventricular hypertrophy, noncompaction of left ventricular myocardium, mitral valve abnormalities, hypoplastic left heart, abnormal systemic venous return and visceral situs inversus have also been reported. 1 -7 Intra-and inter-familial phenotypic variability is noted, but there is no correlation between the mutant alleles and the phenotype. Identification of larger number of mutations and patients would allow more detailed genotype -phenotype comparison. In human, 29 heterozygous mutations have been identified in CSX/NKX2-5 1,3 -11 (MIM# 600584). Most of them (62%) are amino-acid substitutions, and premature STOP codons are identified in the rest of the patients. In addition, a CSX/NKX2-5 screening of 68 formalin-fixed cardiac tissue samples revealed 53 nucleotide changes, but up to 14 nonsynonymous substitutions were identified in a single sample. The authors considered them somatic and mosaic in origin. 12 The disease causative effect needs to be evaluated, as the changes could be artifacts owing to formalin fixation and paraffin embedding. Two mouse models have helped to understand the molecular basis of the cardiac defects observed in patients carrying CSX/NKX2-5 mutations. 13, 14 In heterozygous Csx/ Nkx2-5 knockout (KO) mice, the number of cells in the cardiac conduction system is directly related to Csx/Nkx2-5 gene dosage, and it was stipulated that the specific functional defects associated with Csx/Nkx2-5 loss of function can be attributed to hypoplastic development of the relevant structures in the conduction system. Mice homozygous for a ventricular restricted KO of Csx/Nkx2-5 actually displayed no structural defects, yet had a massive overgrowth of trabecular muscle and progressive complete heart block owing to hypoplastic AV node at birth. We report a novel CSX/NKX2-5 mutation identified in a three-generation family with inherited ASD and conduction defects. Detailed phenotypic characterization showed that the conduction defect always resides in the AV node. Interestingly, two family members had syncopes and three had atrial fibrillation. Blood samples were collected from the participants. Genomic DNA was extracted with the Puregene TM Kit (Gentra Systems).
Materials and methods

Exonic mutation screening
Mutation screening was performed for all the individuals for whom DNA was available, by single-stranded conformation polymorphism (SSCP), heteroduplex analysis and direct sequencing. We used the previously described primer sets and conditions. 3 
Results
Clinical data
Seven affected individuals, four sporadic and three index cases of families, were analysed in this study. Three sporadic individuals had an ASD secundum in association with an AV block, and the fourth had only syncopes. The index case of one of the families (family AC-90) presented an ASD secundum and a right bundle branch block, two family members had an ASD with normal ECG (Figure 1e ). The second index case had an ASD primum without conduction abnormalities. In this family (AC-83), two other individuals presented an ASD secundum, a slightly asymmetric aortic valve without dysfunction and a borderline congenital AV block grade 1 (Figure 1d ). 
Autosomal-dominant AV block I Gutierrez-Roelens et al
In family AC-80, individuals in three generations had cardiac involvement (Figure 1a) . Individual I-1 had a second-degree Wenchebach-type AV block and a complete left bundle branch block. A pacemaker was implanted at age 67. In generation II, individual II-2 had a more complex phenotype. He had an atrial ostium secundum septal defect operated at the age of 29 and a mitral valve prolapse. He developed a third-degree AV block, a right bundle branch block and a left anterior fascicular block. A pacemaker was implanted at age 46. Individual II-3 had a second-degree AV block and needed a pacemaker at age 42. In the third generation, individual III-3 had a small ostium secundum ASD and a first-degree AV block. A pacemaker was implanted at age 15 after several syncopes. Individual III-2, at age 22 years, was an apparently asymptomatic mutation carrier with normal AV conduction (PR ¼ 166 ms). A prolonged PR (first-degree AV block) was observed during Holter monitoring. Syncopes occurred in at least two individuals (II-3, III-3), although the blocks (second and first degree, respectively) were at the nodal level. III-3 had a marked positive tilt test with high-degree AV block. A complete AV block of 14 s, without any escape rhythm, was provoked during ATP infusion. Interestingly, atrial fibrillation occurred in three members of the family (I-1, II-2 and II-3). An unexplained run of ventricular tachycardia was incidentally discovered once on Holter monitoring in III-3.
Exonic mutation screening
Exonic mutation screening identified a c.768T4A nucleotide change in the CSX/NKX2-5 coding sequence in family AC-80 (Figure 1b) , which creates a premature termination codon, p.Tyr256X. The substitution cosegregates with the disease in the family (Figure 1c) . One young individual (III-2) carried the mutation and was thought to be asymptomatic. However, Holter monitoring revealed an intermittent first-degree AV block (Figure 1a and c) . None of 110 unrelated, unaffected controls carried this nucleotide change. Among the other two familial and four sporadic cases screened, no exonic mutations in CSX/NKX2-5 were identified.
Discussion
We have identified a novel p. Tyr256X CSX/NKX2-5 mutation in a three-generation family (AC-80) with AV conduction disturbances. Eleven truncating mutations have previously been reported, 1, 4, 6, 7, 11, 15 including a deletion of amino acids 198 -324 (called M198), which occurs carboxy-terminal to the homeodomain, and overlaps with the region deleted in AC-80. The M198 protein showed normal binding and transactivation of a ANF-luciferase reporter, but a decreased ability to form dimers. 8 The consequences of the deletion of the last 68 amino acids owing to the AC-80 p.Tyr256X mutation may be similar.
The clinical data of family AC-80 underscore the phenotypic heterogeneity of cardiac septal defects, and suggests atrial fibrillation and ventricular arrhythmias to be associated with the CSX/NKX2-5 phenotype. The AV block seems to be confined to the AV node and may lead to severe symptoms under vagal stimulation, despite the apparently benign presentation. This, and the lability of AV node conduction in time, suggests the need for preventive measures, and points to the importance of early identification of individuals with CSX/NKX2-5 mutations.
No exonic CSX/NKX2-5 mutations were identified in the other two families with phenotypes similar to AC-80. This can be explained by nondetection of intragenic rearrangements, although one index patient was heterozygous for two exonic polymorphisms, or the presence of another causative gene, as proposed by Megarbane et al. 
